Cargando…
Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631711/ https://www.ncbi.nlm.nih.gov/pubmed/35858371 http://dx.doi.org/10.1182/bloodadvances.2022007826 |
| _version_ | 1784823874975694848 |
|---|---|
| author | Rosenbaum, Cara A. Özbek, Umut Sanchez, Larysa Lagdameo, Jonathan Abrahams, Alex Hassoun, Hani Lahoud, Oscar Niesvizky, Ruben Landau, Heather J. Osman, Keren |
| author_facet | Rosenbaum, Cara A. Özbek, Umut Sanchez, Larysa Lagdameo, Jonathan Abrahams, Alex Hassoun, Hani Lahoud, Oscar Niesvizky, Ruben Landau, Heather J. Osman, Keren |
| author_sort | Rosenbaum, Cara A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9631711 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96317112022-11-04 Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis Rosenbaum, Cara A. Özbek, Umut Sanchez, Larysa Lagdameo, Jonathan Abrahams, Alex Hassoun, Hani Lahoud, Oscar Niesvizky, Ruben Landau, Heather J. Osman, Keren Blood Adv Research Letter American Society of Hematology 2022-09-23 /pmc/articles/PMC9631711/ /pubmed/35858371 http://dx.doi.org/10.1182/bloodadvances.2022007826 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. |
| spellingShingle | Research Letter Rosenbaum, Cara A. Özbek, Umut Sanchez, Larysa Lagdameo, Jonathan Abrahams, Alex Hassoun, Hani Lahoud, Oscar Niesvizky, Ruben Landau, Heather J. Osman, Keren Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis |
| title | Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis |
| title_full | Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis |
| title_fullStr | Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis |
| title_full_unstemmed | Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis |
| title_short | Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis |
| title_sort | phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed al amyloidosis |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631711/ https://www.ncbi.nlm.nih.gov/pubmed/35858371 http://dx.doi.org/10.1182/bloodadvances.2022007826 |
| work_keys_str_mv | AT rosenbaumcaraa phase12studyofixazomibwithcyclophosphamideanddexamethasoneinnewlydiagnosedalamyloidosis AT ozbekumut phase12studyofixazomibwithcyclophosphamideanddexamethasoneinnewlydiagnosedalamyloidosis AT sanchezlarysa phase12studyofixazomibwithcyclophosphamideanddexamethasoneinnewlydiagnosedalamyloidosis AT lagdameojonathan phase12studyofixazomibwithcyclophosphamideanddexamethasoneinnewlydiagnosedalamyloidosis AT abrahamsalex phase12studyofixazomibwithcyclophosphamideanddexamethasoneinnewlydiagnosedalamyloidosis AT hassounhani phase12studyofixazomibwithcyclophosphamideanddexamethasoneinnewlydiagnosedalamyloidosis AT lahoudoscar phase12studyofixazomibwithcyclophosphamideanddexamethasoneinnewlydiagnosedalamyloidosis AT niesvizkyruben phase12studyofixazomibwithcyclophosphamideanddexamethasoneinnewlydiagnosedalamyloidosis AT landauheatherj phase12studyofixazomibwithcyclophosphamideanddexamethasoneinnewlydiagnosedalamyloidosis AT osmankeren phase12studyofixazomibwithcyclophosphamideanddexamethasoneinnewlydiagnosedalamyloidosis |